Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.74) per share. This is a 7.5 percent increase over losses of $(0.80) per share from the same period last year.
Gossamer Bio Q2 EPS $(0.74) Up From $(0.80) YoY
Gossamer Bio (NASDAQ:GOSS) reported quarterly losses of $(0.74) per share. This is a 7.5 percent increase over losses of $(0.80) per share from the same period last year.
Related Posts
HC Wainwright Sees 40% Upside For This Once Battered Stock With Pipeline Turnaround
September 19, 2:02 PM
HC Wainwright is assuming coverage on AnaptysBio Inc (NASDAQ:ANAB) with a Buy Rating and a price target of $35 at a unique inflection…
Brown & Brown Q4 Adj. EPS $0.50 Beats $0.46 Estimate, Sales $901.40M Beat $897.07M Estimate
January 23, 6:36 PM
Brown & Brown (NYSE:BRO) reported quarterly earnings of $0.50 per share which beat the analyst consensus estimate of $0.46 by 8.7 percent. This is a 19.05 percent increase over earnings of $0.42 per share from the same
US Stocks Open Higher; Vail Resorts Earnings Miss Views
June 9, 9:53 AM
U.S. stocks traded higher this morning, with Nasdaq Composite gaining around 100 points on Friday.
Following the market opening Friday, the Dow traded up 0.13% to 33,878.53 while the NASDAQ rose 0.72% to 13,334.06. The S&P 500, also rose, gaining, 0.39% to 4,310.77.